World’s Premier Precision Medicine Conference (PMWC 2019) Opens 10th Annual Meeting in California’s Silicon Valley; Awards Given to Four Major Contributors to Advance of Precision Medicine

>The Precision Medicine World Conference (PMWC 2019) opened its tenth annual meeting ("Celebrating 10 Years of Precision Medicine Innovation) Sunday evening, January 20, in Santa Clara, Caifornia, with an awards ceremony honoring four distinguished contributors to the advance of precision medicine. ( Live tweets from the conference can be accessed on Twitter using @JohRONeill1 or #pmwc19 ). The award recipients were Carl June, MD, PhD, (Director, Center for Cellular Immunotherapies, University of Pennsylvania) for developing CAR-T therapy (the world’s first gene-based cancer therapy); Feng Zhang, PhD, (Professor, Neuroscience, MIT/Broad) for spearheading the development of optogenetics and CRISPR; George Yancopoulos, MD, PhD, (President & CSO & Director, Regeneron Pharmaceuticals) for developing foundational technologies designed to invent groundbreaking therapies; and Sharon Terry (President, Genetic Alliance) for initiating the movement to build systems for individuals to access and share health data. The master of ceremonies for the awards event was Dawn Berry (Co-Founder & President, Luna DNA) and she opened the evening by welcoming everyone and then introduced event organize Tal Behar (Co-Founder & President, PMWC, LLC) to make some opening remarks. Behar first expressed her thanks the Program Co-Chairs Nancy Davidson, MD (Director Clinical Research Division, Fred Hutchinson Cancer Research Center), and India Hook-Barnard, PhD (Director Research Strategy, UCSF), and then introduced Program Chairman William Dalton, MD, PhD (former President, CEO & Center Director of the Moffitt Cancer Center) to kick off the awards ceremony.
Login Or Register To Read Full Story